Delve into Sanofi's "play to win" strategy as investments are ramping up after their consumer health division's divestment.

The consumer business also agreed to keep its headquarters in the country. Sanofi’s shares traded 0.2% lower on Monday morning in Paris. The stock has risen about 2% over the past 12 months.

The consumer business also agreed to keep its headquarters in the country. Sanofi’s shares traded 0.2% lower on Monday morning in Paris. The stock has risen about 2% over the past 12 months. Despite ...

Sanofi and the government included maintaining production sites, research and development and Opella's official headquarters in France, as well as investing at least 70 million euros over five years.

The firms have also agreed to maintain Opella's headquarters and R&D activities in France, and they plan to invest a total €70m in the country over the next five years. The news that Sanofi was ...

The firms have also agreed to maintain Opella's headquarters and R&D activities in France, and they plan to invest a total ...

Economy Minister Antoine Armand said a contract between CD&R, Sanofi and the government included maintaining production sites, research and development and Opella's official headquarters in France ...

The French government has warned the United States investment company buying the consumer healthcare division of drugmaker ...

Sanofi announced on Monday that it had entered exclusive talks ... 70 million in Opella's French operations over the next five years and to keep the company's headquarters and research and development ...